Glenmede Trust’s Axogen AXGN Stock Holding History

Glenmede Trust’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-336	Closed	-$3K	–	2459
2020 Q2	$3K	Buy	+336	New	+$3.01K	﹤0.01%	2162

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Trust's AXGN Position: Q3 2020 in Review

Glenmede Trust sold out of Axogen (AXGN) in Q3 2020, closing a stake of 336 shares — an estimated $3K sold.

Glenmede Trust first reported a position in AXGN in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 123 funds tracked by Wall St. Rank hold AXGN as of Q3 2020.

Glenmede Trust reported no remaining Axogen position as of Q3 2020 after selling out during the quarter.
Glenmede Trust sold 336 Axogen shares in Q3 2020, an estimated $3K.
Glenmede Trust first reported a position in Axogen in Q2 2020 and held it in 1 quarter.
Glenmede Trust's Axogen position peaked at $3K in Q2 2020.
123 funds tracked by Wall St. Rank held Axogen as of Q3 2020.

Based on Glenmede Trust's 13F filing for Q3 2020, filed 16 Nov 2020.